Specific Targets for Antiviral Drugs

Overview

Journal Biochem J

Specialty Biochemistry

Date 1982 Jul 1

PMID 6181775

Citations 16

Authors

E De Clercq

Affiliations

Soon will be listed here.

Citing Articles

Potential roles of medicinal plants for the treatment of viral diseases focusing on COVID-19: A review.

Adhikari B, Marasini B, Rayamajhee B, Bhattarai B, Lamichhane G, Khadayat K Phytother Res. 2020; 35(3):1298-1312.

PMID: 33037698 PMC: 7675695. DOI: 10.1002/ptr.6893.

Chapter 3 Antiviral drugs: general considerations.

Perspect Med Virol. 2020; 1:93-126.

PMID: 32287578 PMC: 7133937. DOI: 10.1016/S0168-7069(08)70011-9.

The evolution of nucleoside analogue antivirals: A review for chemists and non-chemists. Part 1: Early structural modifications to the nucleoside scaffold.

Seley-Radtke K, Yates M Antiviral Res. 2018; 154:66-86.

PMID: 29649496 PMC: 6396324. DOI: 10.1016/j.antiviral.2018.04.004.

Kinetic studies with N2-phenylguanines and with L-thymidine indicate that herpes simplex virus type-1 thymidine kinase and thymidylate kinase share a common active site.

Maga G, Focher F, Wright G, Capobianco M, Garbesi A, Bendiscioli A Biochem J. 1994; 302 ( Pt 1):279-82.

PMID: 8068016 PMC: 1137220. DOI: 10.1042/bj3020279.

Inhibition of vaccinia virus growth and virus-specific RNA synthesis by 3'-O-methyl adenosine and 3'-O-methyl guanosine.

Goswami B, SHARMA O J Virol. 1983; 45(3):1164-7.

PMID: 6834481 PMC: 256527. DOI: 10.1128/JVI.45.3.1164-1167.1983.

References

De Clercq E, Descamps J, DE SOMER P, Barr P, Jones A, Walker R . (E)-5-(2-Bromovinyl)-2'-deoxyuridine: a potent and selective anti-herpes agent. Proc Natl Acad Sci U S A. 1979; 76(6):2947-51. PMC: 383727. DOI: 10.1073/pnas.76.6.2947. View

Skehel J, Hay A, Armstrong J . On the mechanism of inhibition of influenza virus replication by amantadine hydrochloride. J Gen Virol. 1978; 38(1):97-110. DOI: 10.1099/0022-1317-38-1-97. View

Peterslund N, Ipsen J, ESMANN V, Schonheyder H, Juhl H . Acyclovir in herpes zoster. Lancet. 1981; 2(8251):827-30. DOI: 10.1016/s0140-6736(81)91102-8. View

Saral R, BURNS W, Laskin O, SANTOS G, Lietman P . Acyclovir prophylaxis of herpes-simplex-virus infections. N Engl J Med. 1981; 305(2):63-7. DOI: 10.1056/NEJM198107093050202. View

WATANABE K, Reichman U, Hirota K, Lopez C, Fox J . Nucleosides. 110. Synthesis and antiherpes virus activity of some 2'-fluoro-2'-deoxyarabinofuranosylpyrimidine nucleosides. J Med Chem. 1979; 22(1):21-4. DOI: 10.1021/jm00187a005. View

Matsukage A, Ono K, Ohashi A, Takahashi T, Nakayama C, Saneyoshi M . Inhibitory effect of 1-beta-D-arabinofuranosylthymine 5'-triphosphate and 1-beta-D-arabinofuranosylcytosine 5'-triphosphate on DNA polymerases from murine cells and oncornavirus. Cancer Res. 1978; 38(9):3076-9. View

Schildkraut I, Cooper G, Greer S . Selective inhibition of the replication of herpes simplex virus by 5-halogenated analogues of deoxycytidine. Mol Pharmacol. 1975; 11(2):153-8. View

Goswami B, BOREK E, SHARMA O, Fujitaki J, Smith R . The broad spectrum antiviral agent ribavirin inhibits capping of mRNA. Biochem Biophys Res Commun. 1979; 89(3):830-6. DOI: 10.1016/0006-291x(79)91853-9. View

Pancic F, STEINBERG B, Diana G, CARABATEAS P, GORMAN W, Came P . Antiviral activity of Win 41258-3, a pyrazole compound, against herpes simplex virus in mouse genital infection and in guinea pig skin infection. Antimicrob Agents Chemother. 1981; 19(3):470-6. PMC: 181456. DOI: 10.1128/AAC.19.3.470. View

10.

Selby P, Powles R, Janeson B, Kay H, Watson J, Thornton R . Parenteral acyclovir therapy for herpesvirus infections in man. Lancet. 1979; 2(8155):1267-70. DOI: 10.1016/s0140-6736(79)92281-5. View

11.

Tidwell R, GERATZ J, DANN O, Volz G, Zeh D, LOEWE H . Diarylamidine derivatives with one or both of the aryl moieties consisting of an indole or indole-like ring. Inhibitors of arginine-specific esteroproteases. J Med Chem. 1978; 21(7):613-23. DOI: 10.1021/jm00205a005. View

12.

Zamecnik P, Stephenson M . Inhibition of Rous sarcoma virus replication and cell transformation by a specific oligodeoxynucleotide. Proc Natl Acad Sci U S A. 1978; 75(1):280-4. PMC: 411230. DOI: 10.1073/pnas.75.1.280. View

13.

De Clercq E, Degreef H, Wildiers J, de JONGE G, DROCHMANS A, Descamps J . Oral (E)-5-(2-bromovinyl)-2'-deoxyuridine in severe herpes zoster. Br Med J. 1980; 281(6249):1178. PMC: 1714507. DOI: 10.1136/bmj.281.6249.1178. View

14.

Leavitt R, Schlesinger S, Kornfeld S . Tunicamycin inhibits glycosylation and multiplication of Sindbis and vesicular stomatitis viruses. J Virol. 1977; 21(1):375-85. PMC: 353824. DOI: 10.1128/JVI.21.1.375-385.1977. View

15.

Muller W, Zahn R, Arendes F, Falke D . Phosphorylation of arabinofuranosylthymine in non-infected and herpesvirus (TK+ and TK-)-infected cells. J Gen Virol. 1979; 43(2):261-71. DOI: 10.1099/0022-1317-43-2-261. View

16.

Carrasco L . Membrane leakiness after viral infection and a new approach to the development of antiviral agents. Nature. 1978; 272(5655):694-9. DOI: 10.1038/272694a0. View

17.

Dawson K, Stewart A, Stebbing N . Absence of significant antiviral effects of beta-gamma-methylene GTP on encephalomyocarditis virus infection of L cells and mice. J Gen Virol. 1979; 45(1):237-40. DOI: 10.1099/0022-1317-45-1-237. View

18.

Mitchell C, Bean B, Gentry S, Groth K, Boen J, Balfour Jr H . Acyclovir therapy for mucocutaneous herpes simplex infections in immunocompromised patients. Lancet. 1981; 1(8235):1389-92. DOI: 10.1016/s0140-6736(81)92569-1. View

19.

Prusoff W, Goz B . Potential mechanisms of action of antiviral agents. Fed Proc. 1973; 32(6):1679-87. View

20.

Smith C, Charette R, Fox J, COONEY M, Hall C . Lack of effect of oral ribavirin in naturally occurring influenza A virus (H1N1) infection. J Infect Dis. 1980; 141(5):548-54. DOI: 10.1093/infdis/141.5.548. View